VTGN Vistagen Therapeutics, Inc.
Nasdaq · SEC CIK 1411685 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 91 since 2021-07-02, latest 2026-07-31 08:56
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Prince Joshua S. | COO | — | — |
| Adler Reid G. | CLO | — | — |
| Tressler Nick B. | CFO | — | — |
| Singh Shawn | Pres, CEO, Dir | — | — |
Transactions 45
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 16:34 | 2026-06-30 | VTGN | Adler Reid G. | CLO | A - Grant | $0.1921 | +36.8K | 60.9K | +153% | +$7,073 | |
| 2026-07-02 16:17 | 2026-06-30 | VTGN | Tressler Nick B. | CFO | A - Grant | $0.1921 | +11.7K | 11.7K | New | +$2,250 | |
| 2026-07-02 16:16 | 2026-06-30 | VTGN | Singh Shawn | Pres, CEO, Dir | A - Grant | $0.1921 | +36.8K | 54.8K | +204% | +$7,073 | |
| 2026-01-05 | 2025-12-31 | VTGN | Prince Joshua S. | COO | A - Grant | $0.56 | +4,386 | 15.2K | +40% | +$2,456 | |
| 2025-07-01 | 2025-06-30 | VTGN | Anderson Cynthia Lynn | CFO | A - Grant | $1.70 | +6,617 | 12.8K | +107% | +$11.2K | |
| 2025-07-01 | 2025-06-30 | VTGN | Prince Joshua S. | COO | A - Grant | $1.70 | +4,882 | 10.9K | +82% | +$8,299 | |
| 2025-07-01 | 2025-06-30 | VTGN | Adler Reid G. | CLO | A - Grant | $1.70 | +7,541 | 24.1K | +46% | +$12.8K | |
| 2025-07-01 | 2025-06-30 | VTGN | Singh Shawn | Pres, CEO, Dir | A - Grant | $1.70 | +7,541 | 18.0K | +72% | +$12.8K | |
| 2025-01-13 | 2024-12-31 | VTGN | Prince Joshua S. | COO | A - Grant | $2.51 | +3,310 | 5,981 | +124% | +$8,308 | |
| 2025-01-13 | 2024-12-31 | VTGN | Anderson Cynthia Lynn | CFO | A - Grant | $2.51 | +2,592 | 6,184 | +72% | +$6,506 | |
| 2024-07-02 | 2024-06-28 | VTGN | Anderson Cynthia Lynn | CFO | A - Grant | $2.96 | +3,592 | 3,592 | New | +$10.6K | |
| 2024-07-02 | 2024-06-28 | VTGN | Singh Shawn | CEO, Dir | A - Grant | $2.96 | +4,854 | 10.5K | +86% | +$14.4K | |
| 2024-07-02 | 2024-06-28 | VTGN | Prince Joshua S. | COO | A - Grant | $2.96 | +2,671 | 2,671 | New | +$7,906 | |
| 2024-07-02 | 2024-06-28 | VTGN | Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | A - Grant | $2.96 | +4,854 | 16.5K | +42% | +$14.4K | |
| 2024-01-03 | 2023-12-29 | VTGN | Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | A - Grant | $1.72 | +167 | 11.7K | +1% | +$287.24 | |
| 2024-01-03 | 2023-12-29 | VTGN | Singh Shawn | CEO, Dir | A - Grant | $1.72 | +167 | 5,633 | +3% | +$287.24 | |
| I | 2023-08-09 | 2023-08-07 | VTGN | COMMODORE CAPITAL LP | 10% | P - Purchase | $23.15 | +775.8K | 1.57M | +97% | +$17.96M |
| 2023-07-05 | 2023-06-30 | VTGN | Adler Reid G. | CLO | A - Grant | $1.59 | +167 | 11.5K | +1% | +$265.53 | |
| 2023-07-05 | 2023-06-30 | VTGN | Singh Shawn | CEO, Dir | A - Grant | $1.59 | +167 | 5,466 | +3% | +$265.53 | |
| 2023-07-05 | 2023-06-30 | VTGN | DOTSON JERROLD DUANE | VP, CFO | A - Grant | $1.59 | +167 | 3,671 | +5% | +$265.53 | |
| 2023-01-03 | 2022-12-30 | VTGN | Singh Shawn | CEO, Dir | A - Grant | $0.09 | +5,000 | 159.0K | +3% | +$450 | |
| 2023-01-03 | 2022-12-30 | VTGN | DOTSON JERROLD DUANE | VP, CFO AND Sec | A - Grant | $0.09 | +5,000 | 105.1K | +5% | +$450 | |
| I | 2022-08-22 | 2022-08-18 | VTGN | GIN JERRY B | Dir | P - Purchase | $0.18 | +100.0K | 100.0K | New | +$18.0K |
| 2022-08-22 | 2022-08-18 | VTGN | GIN JERRY B | Dir | P - Purchase | $0.18 | +100.0K | 100.0K | New | +$18.0K | |
| 2022-08-19 | 2022-08-17 | VTGN | Adler Reid G. | CLO | P - Purchase | $0.17 | +300.0K | 334.6K | +866% | +$51.0K | |
| I | 2022-08-18 | 2022-08-17 | VTGN | Singh Shawn | CEO, Dir | P - Purchase | $0.17 | +600.0K | 626.2K | +2,287% | +$102.0K |
| 2022-07-15 | 2022-06-30 | VTGN | Smith Mark Alan | Chief MEDICAL Off | A - Grant | $0.75 | +5,000 | 19.9K | +34% | +$3,750 | |
| 2022-07-15 | 2022-06-30 | VTGN | Singh Shawn | CEO, Dir | A - Grant | $0.75 | +5,000 | 154.0K | +3% | +$3,750 | |
| 2022-07-15 | 2022-07-30 | VTGN | DOTSON JERROLD DUANE | VP, CFO AND Sec | A - Grant | $0.75 | +5,000 | 100.1K | +5% | +$3,750 | |
| I | 2022-07-14 | 2022-07-12 | VTGN | VHCP Management II, LLC | 10% | S - Sale | $0.89 | -60.0K | 20.64M | -0.3% | -$53.4K |
| D | 2022-05-16 | 2022-05-12 | VTGN | Singh Shawn | CEO, Dir | M - OptEx | $1.00 | +100.0K | 149.0K | +204% | +$100.0K |
| D | 2022-01-12 | 2022-01-11 | VTGN | DOTSON JERROLD DUANE | VP, CFO AND Sec | M - OptEx | $1.00 | +18.8K | 94.6K | +25% | +$18.8K |
| 2022-01-03 | 2021-12-31 | VTGN | DOTSON JERROLD DUANE | VP, CFO AND Sec | A - Grant | $1.66 | +3,575 | 75.8K | +5% | +$5,934 | |
| 2022-01-03 | 2021-12-31 | VTGN | Pres, CSO | A - Grant | $1.66 | +3,623 | 65.0K | +6% | +$6,014 | ||
| 2022-01-03 | 2021-12-31 | VTGN | Smith Mark Alan | Chief MEDICAL Off | A - Grant | $1.66 | +2,655 | 14.9K | +22% | +$4,407 | |
| 2022-01-03 | 2021-12-31 | VTGN | Singh Shawn | CEO, Dir | A - Grant | $1.66 | +3,623 | 49.0K | +8% | +$6,014 | |
| 2021-09-08 | 2021-09-07 | VTGN | DOTSON JERROLD DUANE | VP, CFO AND Sec | S - Sale | $3.13 | -30.0K | 72.8K | -29% | -$93.9K | |
| I | 2021-09-03 | 2021-08-23 | VTGN | SNODGRASS H. RALPH | Pres, CSO | G - Gift | $0.00 | -740 | 33.9K | -2% | $0 |
| 2021-09-03 | 2021-09-02 | VTGN | SNODGRASS H. RALPH | Pres, CSO | G - Gift | $0.00 | +1,111 | 61.3K | +2% | $0 | |
| I | 2021-08-18 | 2021-08-17 | VTGN | SNODGRASS H. RALPH | Pres, CSO | P - Purchase | $2.73 | +3,750 | 34.6K | +12% | +$10.2K |
| 2021-07-02 | 2021-06-30 | VTGN | SNODGRASS H. RALPH | Pres, CSO | A - Grant | $1.95 | +3,391 | 91.1K | +4% | +$6,612 | |
| 2021-07-02 | 2021-06-30 | VTGN | Singh Shawn | CEO, Dir | A - Grant | $1.95 | +5,000 | 45.4K | +12% | +$9,750 | |
| DM | 2021-07-02 | 2021-06-30 | VTGN | DOTSON JERROLD DUANE | VP, CFO AND Sec | M - OptEx | $0.9399 | +89.7K | 14.0K | New | +$84.3K |
| D | 2021-07-02 | 2021-06-30 | VTGN | DOTSON JERROLD DUANE | VP, CFO AND Sec | A - Grant | $1.95 | +3,044 | 13.0K | +30% | +$5,936 |
| 2021-07-02 | 2021-06-30 | VTGN | Smith Mark Alan | Chief MEDICAL Off | A - Grant | $1.95 | +2,260 | 12.3K | +23% | +$4,407 |
Purchase Sale Sale after option exercise All abbreviations